Modus Therapeutics Holding AB (MODTX) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.552x

Based on the latest financial reports, Modus Therapeutics Holding AB (MODTX) has a cash flow conversion efficiency ratio of -0.552x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-5.00 Million ≈ $-538.40K USD) by net assets (Skr9.07 Million ≈ $976.18K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Modus Therapeutics Holding AB - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Modus Therapeutics Holding AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MODTX current and long-term liabilities for a breakdown of total debt and financial obligations.

Modus Therapeutics Holding AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Modus Therapeutics Holding AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cheetah Net Supply Chain Service Inc. Class A Common Stock NASDAQ:CTNT	-0.059x
Tingo Group Inc. NASDAQ:TIO	0.409x
BTU Metals Corp V:BTU	-0.025x
First Venture Sweden AB Series B ST:FIRST-B	-0.027x
Pelangi Indah Canindo Tbk JK:PICO	0.081x
Ecofibre Ltd AU:EOF	-0.290x
Wool Industry Tria Alfa S.A. AT:AAAK	N/A
Sentage Holdings Inc NASDAQ:SNTG	-0.088x

Annual Cash Flow Conversion Efficiency for Modus Therapeutics Holding AB (2018–2025)

The table below shows the annual cash flow conversion efficiency of Modus Therapeutics Holding AB from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Modus Therapeutics Holding AB (MODTX) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr9.07 Million ≈ $976.18K	Skr-18.07 Million ≈ $-1.95 Million	-1.993x	+71.00%
2024-12-31	Skr2.14 Million ≈ $229.98K	Skr-14.68 Million ≈ $-1.58 Million	-6.870x	-628.09%
2023-12-31	Skr17.68 Million ≈ $1.90 Million	Skr-16.68 Million ≈ $-1.80 Million	-0.944x	-111.23%
2022-12-31	Skr-2.58 Million ≈ $-278.19K	Skr-21.72 Million ≈ $-2.34 Million	8.404x	+922.46%
2021-12-31	Skr15.73 Million ≈ $1.69 Million	Skr-16.08 Million ≈ $-1.73 Million	-1.022x	+1.16%
2020-12-31	Skr7.00 Million ≈ $752.77K	Skr-7.23 Million ≈ $-778.17K	-1.034x	-106.33%
2019-12-31	Skr-2.69 Million ≈ $-289.06K	Skr-43.90 Million ≈ $-4.72 Million	16.343x	+1075.08%
2018-12-31	Skr23.90 Million ≈ $2.57 Million	Skr-40.06 Million ≈ $-4.31 Million	-1.676x	--

About Modus Therapeutics Holding AB

ST:MODTX Sweden Biotechnology

Market Cap

$5.37 Million

Skr49.87 Million SEK

Market Cap Rank

#28214 Global

#634 in Sweden

Share Price

Skr0.41

Change (1 day)

-2.38%

52-Week Range

Skr0.27 - Skr3.83

All Time High

Skr6.80